Mirabaud Asset Management Ltd Purchases 8,742 Shares of The Clorox Company $CLX

Mirabaud Asset Management Ltd grew its position in The Clorox Company (NYSE:CLX) by 158.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,253 shares of the company’s stock after buying an additional 8,742 shares during the period. Mirabaud Asset Management Ltd’s holdings in Clorox were worth $1,437,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares in the last quarter. Woodline Partners LP increased its position in shares of Clorox by 253.7% during the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after purchasing an additional 7,465 shares in the last quarter. Baird Financial Group Inc. increased its position in shares of Clorox by 1.7% during the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after purchasing an additional 424 shares in the last quarter. Jump Financial LLC increased its position in shares of Clorox by 173.5% during the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after purchasing an additional 7,924 shares in the last quarter. Finally, Bank of Nova Scotia increased its position in shares of Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after purchasing an additional 3,352 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Unusual options activity showed strong bullish speculation, with traders buying 14,071 CLX call options on Friday, far above the typical daily volume. This may signal expectations for a rebound.
• Positive Sentiment: Several articles highlighted Clorox as a high-yield dividend stock, noting its roughly 5.7% yield and its potential to become a Dividend King in 2027 if it continues raising payouts.
• Positive Sentiment: A director reportedly bought about $429,100 worth of Clorox shares, which investors often view as a sign of insider confidence.
• Neutral Sentiment: Long-term performance commentary emphasized Clorox’s consistency as a consumer staples company, with steady dividends and resilience over the past decade, but without a clear new catalyst for near-term earnings. If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff
• Negative Sentiment: Pomerantz LLP said it is investigating claims on behalf of Clorox investors, adding legal uncertainty that could weigh on the stock. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company – CLX
• Negative Sentiment: Commentary noted that Clorox has fallen to an 11-year low, reflecting weaker investor confidence despite its dividend yield. Contrarian Take: This High-Yield Dividend Stock Is a Buy in May Despite Falling to an 11-Year Low

Analyst Ratings Changes

CLX has been the topic of a number of recent analyst reports. Weiss Ratings raised Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. Rothschild & Co Redburn set a $117.00 price target on Clorox in a research report on Friday, February 13th. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Royal Bank Of Canada reduced their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Finally, JPMorgan Chase & Co. reduced their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus price target of $104.00.

Clorox Price Performance

NYSE CLX opened at $92.04 on Monday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The stock’s fifty day moving average price is $106.03 and its 200 day moving average price is $108.04. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $138.23. The company has a market cap of $11.13 billion, a price-to-earnings ratio of 14.94, a PEG ratio of 0.48 and a beta of 0.59.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the firm earned $1.45 EPS. The firm’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts forecast that The Clorox Company will post 5.63 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were given a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 5.4%. The ex-dividend date of this dividend was Wednesday, April 22nd. Clorox’s dividend payout ratio is presently 80.52%.

Insider Activity

In other news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is currently owned by insiders.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.